2010
DOI: 10.1159/000305931
|Get access via publisher |Summarize |Cite
|
Sign up to set email alerts

Local Administration of 1% Ubretid in the Handling of Glaucoma, Myasthenia Gravis and Esotropia

Search citation statements

Order By: Relevance

Paper Sections

Select...
8
2
0
0

Citation Types

0
5
0
0

Year Published

Range
1972
1972
2021
2021

Publication Types

Select...
8
2

Relationship

0
10

Authors

Journals

citations

Cited by 10 publications

(5 citation statements)
references

References 11 publications

0
5
0
0
Order By: Relevance
How this paper cites the one you are viewing
“…1). Distigmine is used clinically in some Asian and European countries, including Japan and Germany, [2][3][4][5][6][7][8] and the main clinical indication for distigmine is myasthenia gravis. 2,9) However, in Japan, distigmine has also been used for glaucoma 3) and an underactive bladder.…”
mentioning
confidence: 99%
“…Distigmine is used clinically in some Asian and European countries, including Japan and Germany, [2][3][4][5][6][7][8] and the main clinical indication for distigmine is myasthenia gravis. 2,9) However, in Japan, distigmine has also been used for glaucoma 3) and an underactive bladder. [4][5][6][7][8] The effectiveness and usefulness of distigmine for underactive bladder treatment have been shown in many clinical studies.…”
mentioning
confidence: 99%
See 1 more Smart Citation